TMO vs DHR — Key Metrics
| Metric | TMO (THERMO FISHER SCIENTIFIC INC) | DHR (DANAHER CORP) |
|---|---|---|
| Price | 692.74 | 228.58 |
| Market Cap | 256.67 Billion | 160.81 Billion |
| P/E (TTM) | 36.48 | 37.35 |
| P/B (Quarterly) | 4.716 | 3.068 |
| P/S (TTM) | 5.42 | 6.28 |
| Net Profit Margin (TTM) | 14.9 | 16.9 |
| Gross Margin (TTM) | 41.1 | 58.6 |
| ROE (TTM) | 13.3 | 8.2 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Underperform
Underperform
Recommendation Summary
Stock TMO is projected to greatly underperform the market, stock DHR is projected to underperform the market. Upfront Recommendation: DHR.
Financial Metrics
| TMO | Metrics | DHR |
|---|---|---|
| $692.74 | Price | $228.58 |
| — | Market Capitalization | — |
| 36.48 | Price to Earnings Ratio | 37.35 |
| 5.42 | Price to Sales | 6.28 |
| 33.61 | Price to FCF Ratio | 27.96 |
| 13.19 | Price to Gross Profit | 10.72 |
| 182.81 | Price to R&D | 96.3 |
| 10.02 | Price to Current Assets | 10.88 |
TMO vs DHR at a glance
Thermo Fisher Scientific INC (TMO) and Danaher Corp (DHR) are both Diagnostics & Research companies in the Healthcare sector. TMO is the larger, at $256.7 billion in market value against $160.8 billion for DHR, about 1.6 times the size.
On trailing-twelve-month figures, TMO trades at 36.5 times trailing earnings and DHR at 37.4; net profit margins are 14.9% and 16.9%.
The Upfront Investment model currently rates TMO Greatly Underperform and DHR Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.